Background The use of radiolabeled choline as a positron emission tomography (PET)
agent for imaging primary tumors in the prostate has been evaluated extensively over the …

Purpose This study evaluated expected tumor control and normal tissue toxicity for prostate
volumetric modulated arc therapy (VMAT) with and without radiation boosts to an …

Background To assess whether whole-body (WB) bone SPECT/CT provides additional
diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the …

Introduction Thyroid incidentaloma is defined as a thyroid lesion incidentally and newly
detected by imaging techniques performed for an unrelated purpose and especially for a …

Aim: To evaluate the diagnostic accuracy of FDG PET/CT in the detection of asymptomatic
recurrence in patients with malignant melanoma who have had resection of their primary …

Objective (s): We performed a phase IIa clinical trial of trans-1-amino-3-18 F-fluoro-
cyclobutane carboxylic acid (anti-18 F-FACBC), a synthetic amino acid analog for PET, in …

Purpose The aim of this study was to assess the value of combining MRI and 18 F-
fluorocholine (FCH) PET/CT for patients with a biochemical relapse (BR) after prostate …

Purpose To retrospectively review data of a cohort of patients with biochemical progression
after radical prostatectomy, treated according to a uniform institutional treatment policy, to …

Functional radionuclide imaging modalities, now commonly combined with anatomical
imaging modalities computed tomography (CT) or magnetic resonance imaging (single …

Measurements of metabolically active tumor volume (MATV) can be applied to 18F-
fluorocholine PET/CT to quantify whole-body tumor burden. This study evaluated the serial …